Adding a viral protein, NoV B2, helped self-amplifying RNA overcome cellular defenses and produce more target protein without diminishing immune stimulation, potentially enabling future vaccines to use lower doses.
Adding a viral protein, NoV B2, helped self-amplifying RNA overcome cellular defenses and produce more target protein without diminishing immune stimulation, potentially enabling future vaccines to use...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Adding a viral protein, NoV B2, helped self-amplifying RNA overcome cellular defenses and produce more target protein without diminishing immune stimulation, potentially enabling future vaccines to use lower doses.
Open the app view to save this story, compare related coverage, and continue from the same source.